BACKGROUND: Total pancreatectomy (TP) is a complex surgical procedure with significant postoperative morbidity. Despite the narrowed range of indications for TP, the introduction of neoadjuvant chemotherapy and the increasing complexity of surgical resections performed in high-volume centers has increased the number of annually performed TPs, especially regarding malignant disease. The introduction of robotic-assisted pancreatic surgery has provided a novel and minimally invasive approach for TP, yet the feasibility of this technique is still unknown. This study assessed the safety and efficacy of robotic-assisted total pancreatectomy (RTP) compared to conventional open total pancreatectomy (OTP). METHODS: All patients who underwent TP between March 2015 and July 2019 in a high-volume institution for pancreatic surgery were included in this retrospective study. Clinical data and perioperative outcomes were derived from the prospectively maintained institutional database. A 1:1 propensity score matching (PSM) method was utilized to compare the RTP and OTP cohorts to minimize bias. RESULTS: A standardized surgical protocol was utilized for RTP following a learning curve of RPD and RDP. The median operative time for patients who underwent RTP was significantly decreased compared to those who underwent OTP [300 (IQR, 250-360) vs. 360 min (IQR, 300-525), P=0.031]. Additionally, en bloc resection and spleen-preserving rates were also higher in the RTP cohort. Major 30-day morbidity (Clavien-Dindo > IIIa) and 90-day mortality were similar between the two cohorts. After a median follow-up time of 15 (IQR, 8-24) months, both the RTP and OTP cohorts had a comparable quality of life regarding exocrine and endocrine insufficiency. CONCLUSIONS: RTP appears to be safe and feasible when utilized in high-volume centers for the indicated management of benign and highly selected malignant pancreatic disease. However, further prospective randomized studies are needed to assess the feasibility of this approach. 2020 Hepatobiliary Surgery and Nutrition. All rights reserved.
BACKGROUND: Total pancreatectomy (TP) is a complex surgical procedure with significant postoperative morbidity. Despite the narrowed range of indications for TP, the introduction of neoadjuvant chemotherapy and the increasing complexity of surgical resections performed in high-volume centers has increased the number of annually performed TPs, especially regarding malignant disease. The introduction of robotic-assisted pancreatic surgery has provided a novel and minimally invasive approach for TP, yet the feasibility of this technique is still unknown. This study assessed the safety and efficacy of robotic-assisted total pancreatectomy (RTP) compared to conventional open total pancreatectomy (OTP). METHODS: All patients who underwent TP between March 2015 and July 2019 in a high-volume institution for pancreatic surgery were included in this retrospective study. Clinical data and perioperative outcomes were derived from the prospectively maintained institutional database. A 1:1 propensity score matching (PSM) method was utilized to compare the RTP and OTP cohorts to minimize bias. RESULTS: A standardized surgical protocol was utilized for RTP following a learning curve of RPD and RDP. The median operative time for patients who underwent RTP was significantly decreased compared to those who underwent OTP [300 (IQR, 250-360) vs. 360 min (IQR, 300-525), P=0.031]. Additionally, en bloc resection and spleen-preserving rates were also higher in the RTP cohort. Major 30-day morbidity (Clavien-Dindo > IIIa) and 90-day mortality were similar between the two cohorts. After a median follow-up time of 15 (IQR, 8-24) months, both the RTP and OTP cohorts had a comparable quality of life regarding exocrine and endocrine insufficiency. CONCLUSIONS: RTP appears to be safe and feasible when utilized in high-volume centers for the indicated management of benign and highly selected malignant pancreatic disease. However, further prospective randomized studies are needed to assess the feasibility of this approach. 2020 Hepatobiliary Surgery and Nutrition. All rights reserved.
Entities:
Keywords:
Robotic-assisted total pancreatectomy (RTP); open total pancreatectomy (OTP); propensity score matching (PSM)
Authors: Felix Nickel; Caelán Max Haney; Karl Friedrich Kowalewski; Pascal Probst; Eldridge Frederick Limen; Eva Kalkum; Marcus K Diener; Oliver Strobel; Beat Peter Müller-Stich; Thilo Hackert Journal: Ann Surg Date: 2020-01 Impact factor: 12.969
Authors: Thijs de Rooij; Jony van Hilst; Hjalmar van Santvoort; Djamila Boerma; Peter van den Boezem; Freek Daams; Ronald van Dam; Cees Dejong; Eino van Duyn; Marcel Dijkgraaf; Casper van Eijck; Sebastiaan Festen; Michael Gerhards; Bas Groot Koerkamp; Ignace de Hingh; Geert Kazemier; Joost Klaase; Ruben de Kleine; Cornelis van Laarhoven; Misha Luyer; Gijs Patijn; Pascal Steenvoorde; Mustafa Suker; Moh'd Abu Hilal; Olivier Busch; Marc Besselink Journal: Ann Surg Date: 2019-01 Impact factor: 12.969
Authors: Werner Hartwig; Alexander Gluth; Ulf Hinz; Frank Bergmann; Pauline E R Spronk; Thilo Hackert; Jens Werner; Markus W Büchler Journal: Ann Surg Date: 2015-03 Impact factor: 12.969
Authors: Brian A Boone; Mazen Zenati; Melissa E Hogg; Jennifer Steve; Arthur James Moser; David L Bartlett; Herbert J Zeh; Amer H Zureikat Journal: JAMA Surg Date: 2015-05 Impact factor: 14.766
Authors: Wenwei Liu; Suwei Yuan; Fengqing Wei; Jing Yang; Changbin Zhu; Y Yu; Jin Ma Journal: Int J Qual Health Care Date: 2017-10-01 Impact factor: 2.038
Authors: Sjors Klompmaker; Thijs de Rooij; Bas Groot Koerkamp; Anuraj H Shankar; Uwe Siebert; Marc G Besselink; A James Moser Journal: Ann Surg Date: 2021-12-01 Impact factor: 13.787